⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10995808 | 0.77 | — | — | |
| SCHEMBL873410 | 0.76 | — | — | |
| SCHEMBL20551243 | 0.76 | — | — | |
| SCHEMBL891222 | 0.76 | — | — | |
| SCHEMBL974860 | 0.74 | — | — | |
| SCHEMBL8018180 | 0.74 | — | — | |
| SCHEMBL31367824 | 0.73 | GRIK1 (0.32) | — | |
| SCHEMBL14639213 | 0.72 | TSHR (0.30) | — | |
| SCHEMBL15626947 | 0.70 | — | — | |
| SCHEMBL893423 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3758668-B1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH & CIE (CH) | 2022-02-23 | — | — | EP | disclosed |
| US-20210129104-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2021-05-06 | — | — | US | disclosed |
| EP-3758668-A1 | PROCESS FOR PREPARING MICROCAPSULES | Firmenich SA (CH) | 2021-01-06 | — | — | EP | disclosed |
| WO-2020020829-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2020-01-30 | — | — | WO | disclosed |
| EP-2970295-B1 | PYRROLOPYRIDAZINES AS POTASSIUM ION CHANNEL INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-12-28 | — | — | EP | disclosed |
| US-9458164-B2 | Pyrrolopyridazines as potassium ion channel inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-10-04 | — | — | US | disclosed |
| US-20160016961-A1 | PYRROLOPYRIDAZINES AS POTASSIUM ION CHANNEL INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2016-01-21 | — | — | US | disclosed |
| EP-2970295-A1 | PYRROLOPYRIDAZINES AS POTASSIUM ION CHANNEL INHIBITORS | Bristol-Myers Squibb Company (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014143607-A1 | PYRROLOPYRIDAZINES AS POTASSIUM ION CHANNEL INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-09-18 | — | — | WO | disclosed |
| EP-2321319-B1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2012-03-14 | — | — | EP | disclosed |
| US-8044068-B2 | Aminopyrrolidine compound | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2011-10-25 | — | — | US | disclosed |
| US-7998950-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2011-08-16 | — | — | US | disclosed |
| EP-2321319-A1 | ANTIVIRAL COMPOUNDS | Gilead Sciences, Inc. (US) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010011959-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-01-28 | — | — | WO | disclosed |
| US-20100022508-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-01-28 | — | — | US | disclosed |
| US-20090291940-A1 | AMINOPYRROLIDINE COMPOUND | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2009-11-26 | — | — | US | disclosed |
| EP-2003131-A1 | AMINOPYRROLIDINE COMPOUND | Taisho Pharmaceutical Co. Ltd. (JP) | 2008-12-17 | — | — | EP | disclosed |
| EP-0553130-B1 | PYRROLIDINE DIONE DERIVATIVES | PFIZER (US) | 1996-01-03 | — | — | EP | disclosed |
| EP-0553130-A1 | PYRROLIDINE DIONE DERIVATIVES. | PFIZER (US) | 1993-08-04 | — | — | EP | disclosed |
| WO-1992006954-A2 | PYRROLIDINE DIONE DERIVATIVES | PFIZER INC. (US) | 1992-04-30 | — | — | WO | disclosed |